Add to ORKG取得学位 : 博士（医学）, 学位授与番号 : 医博甲第1888号 , 学位授与年月日 : 平成19年9月28日, 学位授与大学 : 金沢大学, 主査教授 : 井上 正樹, 副査教授 : 宮本 謙一 , 矢野 聖
Development of drug resistance is the main reason for low chemotherapy effectiveness in treating ova...
The development of a drug-resistant cell line in vitro can take from 3 to 18 months. However, little...
OBJECTIVE:To identify the proteins involved the compensatory adaptive response to paclitaxel in ovar...
金沢大学医学部附属病院泌尿器科BACKGROUND. Although paclitaxel is used for hormone-resistant prostate cancer, relaps...
BACKGROUND Although paclitaxel is used for hormone-resistant prostate cancer, relapse definitely oc...
Aim: The development of chemotherapy resistance is the major obstacle in the treatment of advanced p...
<div><p>We assessed the capability of paclitaxel, one of the taxanes, to induce death in two prostat...
poster abstractTreatment of drug-resistant cancer cells remains a difficult problem in cancer therap...
Debulking surgery followed by chemotherapy are the standard of care for high-grade serous carcinoma....
Aim: The aim of this study was to establish drug-resistant cell lines and to elucidate mechanisms le...
Paclitaxel (PTX) is a potent anti-neoplastic agent that is highly effective in treating ovarian canc...
W Polsce rak prostaty jest trzecim najczęstszym nowotworem złośliwym występującym u mężczyzn. Jedna...
Objective. To study the biological characteristics of paclitaxel resistant endometrial carcinoma cel...
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and is a major cause of cancer r...
Backgrounds: Despite the clinical success of taxanes, they still have limitations, such as chemoresi...
Development of drug resistance is the main reason for low chemotherapy effectiveness in treating ova...
The development of a drug-resistant cell line in vitro can take from 3 to 18 months. However, little...
OBJECTIVE:To identify the proteins involved the compensatory adaptive response to paclitaxel in ovar...
金沢大学医学部附属病院泌尿器科BACKGROUND. Although paclitaxel is used for hormone-resistant prostate cancer, relaps...
BACKGROUND Although paclitaxel is used for hormone-resistant prostate cancer, relapse definitely oc...
Aim: The development of chemotherapy resistance is the major obstacle in the treatment of advanced p...
<div><p>We assessed the capability of paclitaxel, one of the taxanes, to induce death in two prostat...
poster abstractTreatment of drug-resistant cancer cells remains a difficult problem in cancer therap...
Debulking surgery followed by chemotherapy are the standard of care for high-grade serous carcinoma....
Aim: The aim of this study was to establish drug-resistant cell lines and to elucidate mechanisms le...
Paclitaxel (PTX) is a potent anti-neoplastic agent that is highly effective in treating ovarian canc...
W Polsce rak prostaty jest trzecim najczęstszym nowotworem złośliwym występującym u mężczyzn. Jedna...
Objective. To study the biological characteristics of paclitaxel resistant endometrial carcinoma cel...
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and is a major cause of cancer r...
Backgrounds: Despite the clinical success of taxanes, they still have limitations, such as chemoresi...
Development of drug resistance is the main reason for low chemotherapy effectiveness in treating ova...
The development of a drug-resistant cell line in vitro can take from 3 to 18 months. However, little...
OBJECTIVE:To identify the proteins involved the compensatory adaptive response to paclitaxel in ovar...